Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1977-10-28
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0009-2363
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1343-9
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:890857-Administration, Oral,
pubmed-meshheading:890857-Animals,
pubmed-meshheading:890857-Biopharmaceutics,
pubmed-meshheading:890857-Dogs,
pubmed-meshheading:890857-Injections, Intravenous,
pubmed-meshheading:890857-Kinetics,
pubmed-meshheading:890857-Pyridines,
pubmed-meshheading:890857-Pyrithioxin
|
pubmed:year |
1977
|
pubmed:articleTitle |
Biopharmaceutical study of pyrithioxin following oral and intravenous administration to dog.
|
pubmed:publicationType |
Journal Article
|